Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

BST2 protein and certain T cells increase in early alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Anti-CD19 therapy may help treat SLE and NMOSD.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Mesenchymal stem cells and their secretome may offer a safe and effective treatment for systemic lupus erythematosus.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Estrogen and MLL enzymes work together to regulate genes important for hair growth and leukemia.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.